InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.140 0.02 (0.94%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$800 Notification of cessation of securities - IDX 4 Jun 2025 6:10PM $2.390 $2.140 fallen by 10.46%
$800 Macquarie Conference Presentation 7 May 2025 9:28AM $2.360 $2.140 fallen by 9.32%
$800 Ceasing to be a substantial holder from CGF 5 May 2025 4:26PM $2.390 $2.140 fallen by 10.46%
$800 Change of Registered Office 17 Apr 2025 3:21PM $2.260 $2.140 fallen by 5.31%
$800 Notification of cessation of securities - IDX 9 Apr 2025 11:40AM $2.165 $2.140 fallen by 1.15%
$800 Change in Director's Interest Notice - Toby Hall 8 Apr 2025 8:22AM $2.140 $2.140 fallen by 0%
$800 Application for quotation of securities - IDX 7 Apr 2025 2:12PM $2.140 $2.140 fallen by 0%
$800 Update - Dividend/Distribution - IDX 27 Mar 2025 3:01PM $2.330 $2.140 fallen by 8.15%
$800 Becoming a substantial holder 27 Mar 2025 8:17AM $2.310 $2.140 fallen by 7.36%
$800 Change in Director's Interest Notice - Raelene Murphy 12 Mar 2025 2:16PM $2.225 $2.140 fallen by 3.82%
$800 Change in Director's Interest Notice - Dr Ian Kadish 5 Mar 2025 4:59PM $2.150 $2.140 fallen by 0.47%
$800 Change in Director's Interest Notice - Toby Hall 5 Mar 2025 4:45PM $2.150 $2.140 fallen by 0.47%
$800 Becoming a substantial holder from CGF 28 Feb 2025 4:19PM $2.130 $2.140 risen by 0.47%
$800 Update - Dividend/Distribution - IDX 27 Feb 2025 5:08PM $2.360 $2.140 fallen by 9.32%
$800 Dividend/Distribution - IDX 26 Feb 2025 8:58AM $2.860 $2.140 fallen by 25.17%
$800 FY25 Half Year Results Investor Presentation 26 Feb 2025 8:34AM $2.860 $2.140 fallen by 25.17%
$800 FY25 Half Year Results Media Release 26 Feb 2025 8:16AM $2.860 $2.140 fallen by 25.17%
$800 FY25 Half Year Results App4D and Interim Report 26 Feb 2025 8:12AM $2.860 $2.140 fallen by 25.17%
$800 Initial Director's Interest Notice - Dr Mittal 5 Feb 2025 11:47AM $3.000 $2.140 fallen by 28.67%
$800 Appointment of Radiologist Executive Director 5 Feb 2025 11:46AM $3.000 $2.140 fallen by 28.67%
$800 IDX FY25 Half Year Results Release Date and Conference Call 21 Jan 2025 2:13PM $2.960 $2.140 fallen by 27.70%
$800 Changes to Company Secretary roles 20 Jan 2025 11:13AM $2.960 $2.140 fallen by 27.70%
$800 Ceasing to be a substantial holder from PPT 24 Dec 2024 4:26PM $2.870 $2.140 fallen by 25.44%
$800 Change in substantial holding 24 Dec 2024 2:43PM $2.870 $2.140 fallen by 25.44%
$800 Ceasing to be a substantial holder from CGF 24 Dec 2024 2:25PM $2.870 $2.140 fallen by 25.44%

101 - 125 of 788 results

Page 5 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.